Partnering

Share our vision

CDR-Life has formed a successful partnership with Boehringer Ingelheim, bringing together our antibody fragment expertise with Boehringer’s clinical development and marketing expertise.

We are open to partnering with companies, academic collaborators, and individuals who share our vision and can help bring CDR-Life’s innovations to patients.

Our team has a substantial track record in both forming and working in partnerships between pharma and biotech companies to bring new therapeutics to market for patients.

«Partnering with CDR-Life provides Boehringer Ingelheim with the opportunity to collaborate with a team that has a proven track record developing antibody fragment-based therapeutics…»
Clive R. Wood, Ph.D., Corporate Senior Vice President and Global Head of Discovery Research, Boehringer Ingelheim

Contact us for partnering opportunities.
konstantin.vonschulthess@cdr-life.com

Where to meet us

BioEurope 2024, November 4 – 6, 2024, in Stockholm, Sweden

SITC, November 6 – 10, 2024, in Houston, Texas

Jefferies London 2024, November 19 – 21, 2024, in London, UK

ESMO Immuno Oncology, December 11 – 13, 2024, in Geneva, Switzerland

JPM 2025, January 13 – 16, 2025, in San Francisco, California